Perspective Therapeutics, Inc.
Symbol: CATX (NYSE)
3.49
▲ (1.78%) 0.061
Company Description:
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Key Stats
- Today's Open: $3.53
- Today's High: $3.55
- Today's Low: $3.435
- Today's Volume: 647.83K
- Yesterday Close: $3.43
- Yesterday High: $3.575
- Yesterday Low: $3.39
- Yesterday Volume: 640.30K
- Last Min Volume: 0
- Last Min High: $3.498
- Last Min Low: $3.491
- Last Min VWAP: $0
Company Profile
- Name: Perspective Therapeutics, Inc.
- Website: https://www.perspectivetherapeutics.com
- Listed Date: 2003-12-29
- Location: SEATTLE, WA
- Market Status: Active
- CIK Number: 0000728387
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $254.72M
- Round Lot: 100
- Outstanding Shares: 74.26M
- Asset Type: CS
RECENT FILINGS FOR CATX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-01 | 8-K | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 3 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 3 | View |
| 2025-09-04 | 8-K | View |
| 2025-09-03 | 8-K | View |
| 2025-09-02 | 8-K | View |
| 2025-08-13 | 10-Q | View |
| 2025-08-13 | 8-K | View |
| 2025-08-01 | 8-K | View |
| 2025-07-03 | 8-K | View |
| 2025-06-23 | 8-K | View |
| 2025-06-03 | 8-K | View |
| 2025-05-30 | 8-K | View |
| 2025-05-28 | 8-K | View |
| 2025-05-19 | SD | View |
| 2025-05-12 | 10-Q | View |
| 2025-05-12 | 8-K | View |
| 2025-05-01 | 8-K | View |
Latest News on CATX